FARSHAD YAHYA: Open Payments
NPI 1245858893 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,110 in 55 payments from 8 companies in 2025. Trend: 2023 $1,408 · 2024 $1,064 · 2025 $1,110
Food & beverage: $919Education: $191
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 10 | $319 |
| E.R. Squibb & Sons, L.L.C. | 18 | $205 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $182 |
| Alkermes, Inc. | 8 | $180 |
| Neurocrine BioSciences, Inc. | 5 | $107 |
| Janssen Pharmaceuticals, Inc | 3 | $73 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
Products named: COBENFY, CAPLYTA, ARISTADA, INGREZZA, AUSTEDO XR, INVEGA SUSTENNA, UZEDY, FANAPT.
Industry payments across AZ — which companies pay providers there.
